# Pasithea Therapeutics Corp.: Form 8-K, filed Sep 30, 2024

- Company: [Pasithea Therapeutics Corp.](/companies/ktta.md) (CIK 1841330)
- Form: 8-K
- Filed: 2024-09-30
- Accepted by EDGAR: Sep 30, 2024, 16:49 ET
- Period: 2024-09-26
- Accession: 0001213900-24-083408
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1841330/000121390024083408/ea0215863-8k_pasithea.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1841330/000121390024083408/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1841330/000121390024083408/ea0215863-8k_pasithea.htm

Filed Sep 30, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-083408. Last ingested by Listed: Nov 6, 2026, 16:36 ET. No prices; not investment advice.